According to an initial study, U.S. pharmaceutical company Moderna said Thursday that its updated Corona vaccine was effective against the “Eris” subvariant.
The company now expects to launch the new vaccine in time for the fall vaccination season. However, approval from regulatory authorities is still pending.
New corona sub-variant Eris
Moderna, like vaccine makers Novavax and Pfizer, has been working with BioNTech SE to develop versions of its vaccines that target Eris subvariants. A short while earlier, pharmaceutical company Pfizer announced that a mouse study had shown that its updated vaccine had protected mice against Eris.
Eris is the nickname for EG.5 and is similar to the XBB.1.5 variant, a subvariant of the still-dominant Omicron variant. The World Health Organisation (WHO) has upgraded the new EG.5 coronavirus (Eris) mutation and placed it under increased surveillance.
- source: k.at/picture: pixabay.com
This post has already been read 1778 times!